Ovarian Cancer Clinical Trials

Showing 961-980 of 994 trials

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

NCT00750386

This trial will determine the feasibility and toxicity of dose intense (every 2 weeks) of paclitaxel+carboplatin combination following cytoreductive surgery in patients with stage Ic-IV ovarian cancer.

Ovarian Cancer

Hellenic Oncology Research Group50 participantsStarted Jan 2008

Heraklion, Crete, Greece • Alexandroupoli, Greece • Athens, Greece +9 more locations

UNKNOWN

Korean Hereditary Breast Cancer Study

NCT00595348

1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer. 2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer. 3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation. 4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.

Breast CancerOvarian Cancer

Korean Breast Cancer Study Group2,250 participantsStarted Nov 2007

Seongnam-si, Gyeonggi-do, South Korea

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

Korean Hereditary Breast Cancer Study

Related Searches

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer

Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis

Retrospective Study of Ovarian Cancer Patients With Brain Metastasis

A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Genetic Studies in Breast Cancer

Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

Screening and Identification of Ovarian Cancers

Women Surviving Ovarian Cancer

The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies

Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer